Home/Pipeline/GSK4362676

GSK4362676

Solid Tumors

Phase 1Active

Key Facts

Indication

Solid Tumors

Phase

Phase 1

Status

Active

Company

GSK plc

About GSK plc

GSK plc is one of the world's leading pharmaceutical companies, headquartered in London, with operations in over 100 countries. The company has transformed from a traditional pharmaceutical giant into a focused biopharma company through strategic divestitures and increased R&D investment. GSK maintains leadership positions in respiratory diseases, HIV treatment, vaccines, and has a growing oncology portfolio. The company is publicly traded on the London Stock Exchange and NYSE with a market capitalization exceeding $100 billion.

View full company profile

Therapeutic Areas

Respiratory HIV Oncology Vaccines Immunology Infectious Diseases

Other Solid Tumors Drugs

Drug	Company	Phase	Status
ABBV-154	AbbVie	Phase 1	Active
TAK-981	Takeda Pharmaceutical	Phase 1/2	Active
TAK-676	Takeda Pharmaceutical	Phase 1	Active
TAK-573	Takeda Pharmaceutical	Phase 1	Active
TAK-164	Takeda Pharmaceutical	Phase 1	Active
SHR-1316	Jiangsu Hengrui Medicine	Phase 1/2	Active
BAY 2927088	Bayer	Phase 1	Active
ASP1929	Astellas Pharma	Phase 2	Active
IBI188	Innovent Biologics	Phase 1	Active
Bispecific Antibody	Akeso	Phase 1/2	Active
CSPC-DM02	CSPC Pharmaceutical Group Limited	Phase 2	Active
ONO-4538 combinations	Ono Pharmaceutical	Phase 2	Active